- Home
- PSNL vs PETS Comparison
PSNL vs PETS Comparison
Compare PSNL & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNL | PETS |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.1M | 61.6M |
| IPO Year | 2019 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PSNL | PETS |
|---|---|---|
| Price | $7.53 | $2.32 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 1 |
| Target Price | ★ $11.50 | $3.20 |
| AVG Volume (30 Days) | ★ 1.3M | 88.1K |
| Earning Date | 05-05-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.58 | 18.92 |
| EPS | ★ N/A | N/A |
| Revenue | $69,648,000.00 | ★ $273,800,000.00 |
| Revenue This Year | $16.94 | N/A |
| Revenue Next Year | $36.58 | $2.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.83 | $1.57 |
| 52 Week High | $11.50 | $4.32 |
Technical Indicators
Market Signals| Indicator | PSNL | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 26.21 |
| Support Level | $6.89 | N/A |
| Resistance Level | $7.78 | $2.93 |
| Average True Range (ATR) | 0.54 | 0.12 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 34.25 | 1.80 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.